Cencora to invest $1bn in US pharma distribution network
The second national distribution centre, which is in Harrison, Ohio, will be operational by spring 2027.
Drug Development
Leukogene Therapeutics gains FDA ODD status for M2T-CD33
Avant and SGAustria form JV to develop diabetes therapy
AmacaThera and Pacira sign agreement for AMT-143
Boehringer and CDR-Life announce licensing deal for autoimmune disease therapy
FDA approves UCB’s Kygevvi for genetic mitochondrial disease
Eli Lilly to invest $3bn in new Dutch manufacturing facility
IntoCell and Xcellon Biologics to advance ADC development
